OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

2 Projects | 1 Researchers | $225,000 Invested

2009

New York University

Einar Sigurdsson, PhD

Passive Immunotherapy for Frontotemporal Dementia

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2007

New York University

Einar Sigurdsson, PhD

Clearance of Pathological Tau Conformers

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed